Brief: Livanova Receives U.S. FDA 510(K) Clearance For Essenz Heart-Lung Machine
09/03/2023 21:48
March 9 (Reuters) - LivaNova PLC LIVN.O :
* LIVANOVA RECEIVES U.S. FDA 510(K) CLEARANCE FOR ESSENZ
HEART-LUNG MACHINE FOR CARDIOPULMONARY BYPASS PROCEDURES
Source text for Eikon: ID:nBwbGJWVCa
Further company coverage: LIVN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Livanova
See all newsAIM - Schedule One Update - TEK 4 Holdco Limited
Competition and Mkts - Merger Update: NRG Fleet / Specialist Fleet
LivaNova PLC reports results for the quarter ended June 30 - Earnings Summary
UK's LivaNova Q2 revenue beats estimates; lifts 2026 outlook
Brief: Livanova Demonstrates 84.5% Cumulative Response Rate With Polysync Programming In OSPREY Study